Displaying items by tag: research
Fecal-dominant donor microbes in the recipient patients after fecal microbe transplantation did not correlate with response to anti-PD-1 therapy.
Blood and marrow transplantation strategies have changed significantly over the past four decades; but recipients still experience excess mortality that translates into 8.7 years of life lost, according to researchers in UAB’s Institute for Cancer Outcomes and Survivorship.
Yabing Chen, Ph.D., is the first researcher at the Birmingham VA to receive this highest honor for a non-physician scientist.
The higher infectivity correlates with mutations that increase viral binding to a cell surface glucosaminoglycan, heparan sulfate.
Pharmacogenomics has become a valuable tool for optimizing treatments and is poised to play an increasing role in clinical care.
This grant will allow Amm to develop a new pre-clinical model for surgically removing ameloblastomas to reduce the chance of recurrence in patients.
This finding upends the long-held paradigm that priming during lung infections takes place only in the draining lymph nodes, and it will be key to developing more efficient vaccinations and therapies for respiratory challenges.
A Bcl-2 inhibitor that has FDA approval for treatment of several leukemias reversed lung fibrosis in a bleomycin mouse model.
In this arteriolar niche, breast cancer stem cells and arteriolar endothelial cells cross-talk using a well-known signaling pathway. Targeting this pathway may offer therapeutic potential.
Sixto Leal, M.D., Ph.D., was featured in the “Front(line) and Center” category in the Pathologist's 2021 Power List recognizing some of the most inspirational pathologists and laboratory medicine professionals in the U.S. in 2021.
